Oxford BioMedica PLC banner

Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 625 GBX 9.27% Market Closed
Market Cap: £755.4m

Dividends

Oxford BioMedica PLC
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield
Oxford BioMedica PLC

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Oxford BioMedica PLC

Period
3Y
5Y
10Y
15Y
30Y
Yield Statistics, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

OXB Price
Oxford BioMedica PLC

Annual Price Range
625
52w Low
277
52w High
913
Price Metrics
Average Annual Return -0.05%
Standard Deviation of Annual Returns 75.4%
Max Drawdown -90%
Shares Statistics
Market Capitalization 754.7m GBX
Shares Outstanding 120 870 000
Percentage of Shares Shorted 50%

OXB Return Decomposition
Main factors of price return

Stock Splits

OXB's latest stock split occurred on May 30, 2018

The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.

Before the split, OXB traded at 14.92 per share. Afterward, the share price was about 700.

The adjusted shares began trading on May 30, 2018. This was OXB's 7th stock split, following the previous one in Dec 14, 2010.

Pre-Split Price
746 14.92
Post-Split Price
700
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett